A randomized, double-blind, vehicle-controlled, half-side comparison with a herbal ointment containing Mahonia aquifolium, Viola tricolor and Centella asiatica for the treatment of mild-to-moderate atopic dermatitis

International Journal of Clinical Pharmacology and Therapeutics

Volumn 45, Issue 11, 2007, Pages 583-591

  Klovekorn W ^a,c   Tepe, A ^a   Danesch, U ^b  

^a Department of Dermatology Practice ^*  (Germany)

^b Weber and Weber GmbH and Co KG   (Germany)

^c Hautarztpraxis   (Germany)

Author keywords

Adults; Atopic dermatitis; Ekzevowen ; Herbal ointment

Indexed keywords

ANTIINFLAMMATORY AGENT; CENTELLA ASIATICA EXTRACT; DERMAVEX; EKZEVOWEN DERMA; HERBACEOUS AGENT; LINDERMA; MAHONIA AQUIFOLIUM EXTRACT; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG; VIOLA TRICOLOR EXTRACT;

ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CLIMATE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FATALITY; DRUG FORMULATION; DRUG TOLERABILITY; FEMALE; HUMAN; MAHONIA; MAHONIA AQUIFOLIUM; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OINTMENT; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRURITUS; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT; VIOLA TRICOLOR; VIOLACEAE; VISUAL ANALOG SCALE;

EID: 35748962334     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP45583     Document Type: Article

References (27)

1. Abeck D, Klövekorn W, Danesch U. Behandlung des atopischen Ekzems bei Kindern mit einer pflanzlichen Heilsalbe-Ergebnisse einer offenen Studie mit Ekzevowen derma. Akt Dermatol. 2005; 31: 523-526.
2. Abramovits W, Boguniewicz M; Adult Atopiclair Study Group. A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP (Atopiclair) in the management of mild to moderate atopic dermatitis in adults. J Drugs Dermatol. 2006; 5: 236-244.
3. Abramovits W, Perlmutter A. MimyX cream. Skinmed. 2006; 5: 29-30.
4. Bedi MK, Shenefelt PD. Herbal therapy in dermatology. Arch Dermatol. 2002; 138: 232-242.
5. Belloni G, Pinelli S, Veraldi S. A randomised, double-blind, vehicle-controlled study to evaluate the efficacy and safety of MAS063D (Atopiclair) in the treatment of mild to moderate atopic dermatitis. Eur J Dermatol. 2005; 15: 31-36.
6. Bieber T, Cork M, Ellis C, Girolomoni G, Groves R, Langley R, Luger T, Meurer M, Murrell D, Orlow S, Paller A, de Prost Y, Puig L, Ring J, Saurat JH, Schwarz T, Shear N, Stingl G, Taieb A, Thestrup-Pedersen K, Pediatric Advisory Committee of the Food and Drug Administration. Consensus statement on the safety profile of topical calcineurin inhibitors. Dermatology. 2005; 211: 77-78.
7. Brinkhaus B, Lindner M, Schuppan D, Hahn EG. Chemical, pharmacological and clinical profile of the East Asian medical plant Centella asiatica. Phytomedicine. 2000; 7: 427-448.
8. Brown DJ, Dattner AM. Phytotherapeutic approaches to common dermatologic conditions. Arch Dermatol. 1998; 134: 1401-1404.
9. Ernst E. Are herbal medicines effective? Int J Clin Pharmacol Ther. 2004; 42: 157-159.
10. Gieler U. Neue Perspektiven der Psoriasistherapie mit Mahonia-aquifolium-Therapie mit homöopathischen Externa. Dtsch Dermatol. 1993; 11: 1201-1207.
11. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol. 1980; Suppl. 92: 44-47.
12. Kolbe L, Kligman AM, Schreiner V, Stoudemayer T. Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin. Skin Res Technol. 2001; 7: 73-77.
13. Korting HC, Schafer-Korting M, Klövekorn W, Klövekorn G, Martin C, Laux P. Comparative efficacy of hamamelis distillate and hydrocortisone cream in atopic eczema. Eur J Clin Pharmacol. 1995; 48: 461-465.
14. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest. 2004; 113: 651-657.
15. Levin C, Maibach H. Exploration of "alternative" and "natural" drugs in dermatology. Arch Dermatol. 2002; 138: 207-211.
16. Mezger J. Gesichtete homöopathische Arzneimittellehre. Heidelberg: Karl F. Haug Verlag; 1985.
17. Morse NL, Clough PM. A meta-analysis of randomized, placebo-controlled clinical trials of Efamol evening primrose oil in atopic eczema. Where do we go from here in light of more recent discoveries? Curr Pharm Biotechnol. 2006; 7: 503-524.
18. Novak N, Bieber T, Leung DY. Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol. 2003; 112: 128-139.
19. Patzelt-Wenczler R, Ponce-Poschl E. Proof of efficacy of Kamillosan® cream in atopic eczema. Eur J Med Res. 2000; 5: 171-175.
20. Rajka G, Langeland T. Grading of the severity of atopic dermatitis. Acta Derm Venereol. 1989; Suppl. 144: 13-14.
21. Saeedi M, Morteza-Semnani K, Ghoreishi MR. The treatment of atopic dermatitis with licorice gel. J Dermatol Treat. 2003; 14: 153-157.
22. Schafer L, Kragballe K. Abnormalities in epidermal lipid metabolism in patients with atopic dermatitis. J Invest Dermatol. 1991; 96: 10-15.
23. Schempp CM, Windeck T, Hezel S, Simon JC. Topical treatment of atopic dermatitis with St. John's wort cream - a randomized, placebo-controlled, double-blind half-side comparison. Phytomedicine. 2003; Suppl. 4: 31-37.
24. Takwale A, Tan E, Agarwal S, Barclay G, Ahmed I, Hotchkiss K, Thompson JR, Chapman T, Berth-Jones J. Efficacy and tolerability of borage oil in adults and children with atopic eczema: a randomised, double-blind, placebo-controlled, parallel group trial. BMJ. 2003; 327: 1385-1388.
25. Vocks E, Busch R, Frohlich C, Borelli S, Mayer H, Ring J. Influence of weather and climate on subjective symptom intensity in atopic eczema. Int J Biometeorol. 2001; 45: 27-33.
26. Wiesenauer M. Mahonia aquifolium-Salbe bei psoriasis vulgaris. Z Allgemeinmed. 1992; 68: 670-674.
27. Williams H, Robertson C, Stewart A, Ait-Khaled N, Anabwani G, Anderson R, Asher I, Beasley R, Bjorksten B, Burr M, Clayton T, Crane J, Ellwood P, Keil U, Lai C, Mallol J, Martinez F, Mitchell E, Montefort S, Pearce N, Shah J, Sibbald B, Strachan D, von Mutius E, Weiland SK. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol. 1999; 103: 125-138.